- Home
- ROIV vs USFD Comparison
ROIV vs USFD Comparison
Compare ROIV & USFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | USFD |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Food Distributors |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.7B | 18.8B |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | ROIV | USFD |
|---|---|---|
| Price | $28.05 | $94.68 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 11 |
| Target Price | $27.56 | ★ $103.64 |
| AVG Volume (30 Days) | ★ 4.8M | 2.5M |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.54 |
| EPS | N/A | ★ 2.94 |
| Revenue | $29,053,000.00 | ★ $39,424,000,000.00 |
| Revenue This Year | N/A | $7.64 |
| Revenue Next Year | $385.85 | $3.99 |
| P/E Ratio | ★ N/A | $31.51 |
| Revenue Growth | N/A | ★ 4.08 |
| 52 Week Low | $8.73 | $57.36 |
| 52 Week High | $30.33 | $102.13 |
Technical Indicators
Market Signals| Indicator | ROIV | USFD |
|---|---|---|
| Relative Strength Index (RSI) | 53.51 | 57.24 |
| Support Level | $26.94 | $75.17 |
| Resistance Level | N/A | $102.13 |
| Average True Range (ATR) | 1.01 | 2.20 |
| MACD | -0.21 | -0.73 |
| Stochastic Oscillator | 32.70 | 68.15 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About USFD US Foods Holding Corp.
US Foods Holding Corp is the U.S. food service distributor that distributes food and nonfood products to the healthcare and hospitality industries, restaurants, and education, government facilities, and grocers. It has nearly 250,000 restaurants and foodservice operators with more than 70 locations that provide customers with food offering and a comprehensive suite of e-commerce, technology, and business solutions. The company operates in one business segment in which it markets, sells and distributes fresh, frozen and dry food and non-food products to foodservice customers throughout the U.S.